Tourmaline Bio Company Overview
About Tourmaline Bio
Tourmaline Bio (NASDAQ:TRML) is a biotechnology firm deeply engaged in the development of innovative therapies that aim to transform the treatment landscape for patients with complex diseases. The company leverages cutting-edge research and technology to create a pipeline of potential treatments targeting a variety of medical conditions, demonstrating its commitment to addressing unmet medical needs. Through strategic collaborations and a focus on scientific excellence, Tourmaline Bio aims to advance its projects from discovery through to clinical development. By prioritizing patient health and pioneering novel treatment options, the company's objective is to make a significant impact on the quality of life for patients around the globe, marking its footprint in the biotech industry with a focus on delivering breakthrough therapies.
Snapshot
Operations
Produtos e/ou serviços de Tourmaline Bio
- Development of a proprietary platform for single-cell chromatin accessibility mapping, offering insights into gene regulation.
- Creation of high-resolution immune profiling services to aid in understanding immune-mediated diseases.
- Innovative solutions for the discovery of novel biomarkers using advanced sequencing technologies.
- Collaborative research projects aimed at unraveling the complexities of cancer genetics.
- Custom assay development for specific gene regulation studies tailored to research needs.
- Provision of comprehensive data analysis and interpretation services for genomic research.
equipe executiva do Tourmaline Bio
- Dr. Sandeep C. Kulkarni M.D.Co-Founder, CEO & Director
- Mr. Ryan Robinson CPACFO & Treasurer
- Mr. W. Bradford Middlekauff J.D.Chief Business Officer, General Counsel & Corporate Secretary
- Dr. Susan Dana Jones Ph.D.Chief Technology Officer
- Ms. Kimberly PiorkowskiVice President of People, Culture & Compliance
- Dr. Kevin B. Johnson M.B.A., Ph.D.Chief Regulatory Officer
- Ms. Dora RauSenior VP & Head of Quality
- Mr. Gerhard Hagn Pharm.D.Chief Commercial Officer
- Dr. Emil M. deGoma M.D.Senior Vice President of Medical Research
- Dr. Kristine Erickson O.D., Ph.D.VP & TA Head of Ophthalmology, Medical Research